James A. Rechtin bought $1.5M of Humana (HUM)
Executed May 14 2025, disclosed May 16 2025, 2 days later.
Over the 21 trading sessions from the disclosed entry session (May 16 2025), the stock returned +2.5% (delay-adjusted); from the execution session (May 14 2025), +0.0%. Derived: entry at the session's open, exit at the close 20 sessions later.
James A. Rechtin (President & CEO) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Humana Inc. (HUM). Across 1 priced purchase filing, the average 21-session return was +0.0% from execution and +2.5% from disclosure (delay-adjusted; derived). The largest single filing was $1.5M of HUM (6,530 sh × $229.25, as filed), executed May 14 2025.
Healthcare · Humana Inc. provides medical and specialty insurance products in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→